Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 3
2017 6
2018 6
2019 7
2020 11
2021 1
2022 2
2023 3
2024 4
2025 5
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Identification of fusions with potential clinical significance in melanoma.
Moran JMT, Le LP, Nardi V, Golas J, Farahani AA, Signorelli S, Onozato ML, Foreman RK, Duncan LM, Lawrence DP, Lennerz JK, Dias-Santagata D, Hoang MP. Moran JMT, et al. Mod Pathol. 2022 Dec;35(12):1837-1847. doi: 10.1038/s41379-022-01138-z. Epub 2022 Jul 23. Mod Pathol. 2022. PMID: 35871080 Free article.
Additional fusions, previously reported in melanoma, included: EML4::ALK, MLPH::ALK, AGAP3::BRAF, AGK::BRAF, CDH3::BRAF, CCT8::BRAF, DIP2B::BRAF, EFNB1::RAF1, LRCH3::RAF1, MAP4::RAF1, RUFY1::RAF1, and ADCY2::TERT. Fusion positive melanomas harbored recurrent alterations in …
Additional fusions, previously reported in melanoma, included: EML4::ALK, MLPH::ALK, AGAP3::BRAF, AGK::BRAF, CDH3::BRAF, CCT8::BRAF, DIP2B:: …
Interaction between the EPHB2 receptor and EFNB1 ligand drives gastric cancer invasion and metastasis via the Wnt/beta-catenin/FAK pathway.
Hu Y, Xie Q, Zhao J, Yang R, Qin J, Li H, Zhao Y, Du X, Shi C. Hu Y, et al. Int J Biol Macromol. 2024 Feb;258(Pt 1):128848. doi: 10.1016/j.ijbiomac.2023.128848. Epub 2023 Dec 17. Int J Biol Macromol. 2024. PMID: 38114003
The interaction between the EPHB2 receptor and its cognate-specific EFNB1 ligands was high in GC and correlated with a poor prognosis. Fc-EFNB1 treatment increased the invasion and migration abilities of GC cells and induced a high EPHB2 expression. ...In conclusion …
The interaction between the EPHB2 receptor and its cognate-specific EFNB1 ligands was high in GC and correlated with a poor prognosis …
Eph and Ephrin Variants in Malaysian Neural Tube Defect Families.
Mohd-Zin SW, Tan ACW, Atroosh WM, Thong MK, Azizi AB, Greene NDE, Abdul-Aziz NM. Mohd-Zin SW, et al. Genes (Basel). 2022 May 26;13(6):952. doi: 10.3390/genes13060952. Genes (Basel). 2022. PMID: 35741713 Free PMC article.
We reported that three out of seven spina bifida probands and three out of thirteen family members carried a variant in either EPHA2 (rs147977279), EPHB6 (rs780569137) or EFNB1 (rs772228172). Analysis of public databases shows that these variants are rare. ...
We reported that three out of seven spina bifida probands and three out of thirteen family members carried a variant in either EPHA2 (rs1479 …
Colorectal cancer-associated mutations impair EphB1 kinase function.
Kim Y, Ahmed S, Miller WT. Kim Y, et al. J Biol Chem. 2023 Sep;299(9):105115. doi: 10.1016/j.jbc.2023.105115. Epub 2023 Jul 30. J Biol Chem. 2023. PMID: 37527777 Free PMC article.
The CRC-associated mutations also impair cell compartmentalization in an assay in which EphB1-expressing cells are cocultured with ligand (ephrin B1)-expressing cells. These results suggest that somatic mutations impair the kinase-dependent tumor suppressor function …
The CRC-associated mutations also impair cell compartmentalization in an assay in which EphB1-expressing cells are cocultured with ligand ( …
Proteomic insights into metabolic dysfunction-associated steatotic disease: Identifying therapeutic targets and assessing on-target side effects.
Dai L, Liu Z, Guo C, Fan H, Zhang C, Huang J, Zhang X, Zhao S, Wang H, Zhang T. Dai L, et al. Life Sci. 2025 Jul 15;373:123665. doi: 10.1016/j.lfs.2025.123665. Epub 2025 Apr 24. Life Sci. 2025. PMID: 40287056
Interleukin-6 (IL-6), alpha-1-antitrypsin (alpha1-antitrypsin), 5-hydroxytryptamine receptor 7 (5-HT7R), ephrin-B1 (EFNB1), and protein MENT (CA056) were replicated. Notably, IL-6 (OR = 2.02; 95 % CI 1.54-2.64), 5-HT7R (OR = 2.73; 95 % CI 1.96-3.80), and E …
Interleukin-6 (IL-6), alpha-1-antitrypsin (alpha1-antitrypsin), 5-hydroxytryptamine receptor 7 (5-HT7R), ephrin-B1 (EFNB1 …
EPHRIN-B1 Mosaicism Drives Cell Segregation in Craniofrontonasal Syndrome hiPSC-Derived Neuroepithelial Cells.
Niethamer TK, Larson AR, O'Neill AK, Bershteyn M, Hsiao EC, Klein OD, Pomerantz JH, Bush JO. Niethamer TK, et al. Stem Cell Reports. 2017 Mar 14;8(3):529-537. doi: 10.1016/j.stemcr.2017.01.017. Epub 2017 Feb 23. Stem Cell Reports. 2017. PMID: 28238796 Free PMC article.
Craniofrontonasal syndrome (CFNS) is a rare X-linked disorder caused by mutations in EFNB1 and characterized by craniofacial, skeletal, and neurological anomalies. Heterozygous females are more severely affected than hemizygous males, a phenomenon termed cellular interfere …
Craniofrontonasal syndrome (CFNS) is a rare X-linked disorder caused by mutations in EFNB1 and characterized by craniofacial, skeleta …
NGS targeted screening of 100 Scandinavian patients with coronal synostosis.
Topa A, Rohlin A, Andersson MK, Fehr A, Lovmar L, Stenman G, Kölby L. Topa A, et al. Am J Med Genet A. 2020 Feb;182(2):348-356. doi: 10.1002/ajmg.a.61427. Epub 2019 Dec 14. Am J Med Genet A. 2020. PMID: 31837199
Sixty-five percent of the families had mutations in the CS core genes FGFR2, TWIST1, FGFR3, TCF12, EFNB1, FGFR1, and POR. Five novel pathogenic/likely pathogenic variants in TWIST1, TCF12, and EFNB1 were identified. ...
Sixty-five percent of the families had mutations in the CS core genes FGFR2, TWIST1, FGFR3, TCF12, EFNB1, FGFR1, and POR. Five novel …
Loss of EfnB1 in the osteogenic lineage compromises their capacity to support hematopoietic stem/progenitor cell maintenance.
Arthur A, Nguyen TM, Paton S, Zannettino ACW, Gronthos S. Arthur A, et al. Exp Hematol. 2019 Jan;69:43-53. doi: 10.1016/j.exphem.2018.10.004. Epub 2018 Oct 13. Exp Hematol. 2019. PMID: 30326247 Free article.
The present study examined the influence of EfnB1-expressing osteogenic lineage on HSPC function. Mice with conditional deletion of EfnB1 in the osteogenic lineage (EfnB1(OB)(-/-)), driven by the Osterix promoter, exhibited a reduced prevalence of osteogenic …
The present study examined the influence of EfnB1-expressing osteogenic lineage on HSPC function. Mice with conditional deletion of …
Genetic diagnostic yield in an 11-year cohort of craniosynostosis patients.
Gaillard L, Goverde A, Weerts MJA, de Klein A, Mathijssen IMJ, Van Dooren MF. Gaillard L, et al. Eur J Med Genet. 2023 Oct;66(10):104843. doi: 10.1016/j.ejmg.2023.104843. Epub 2023 Sep 15. Eur J Med Genet. 2023. PMID: 37716645
Diagnostic yield was 11% and was highest for EFNB1, FGFR2, FGFR3, and IL11RA. Diagnostic yield for copy number variant analysis using microarray was 8%. ...
Diagnostic yield was 11% and was highest for EFNB1, FGFR2, FGFR3, and IL11RA. Diagnostic yield for copy number variant analysis using …
Exploring the ceRNA network involving AGAP2-AS1 as a novel biomarker for preeclampsia.
Lu F, Zeng N, Xiao X, Wang X, Gong H, Lei H. Lu F, et al. Sci Rep. 2024 Nov 9;14(1):27330. doi: 10.1038/s41598-024-79224-2. Sci Rep. 2024. PMID: 39521940 Free PMC article.
Further, five hub genes were identified by receiver operating characteristic (ROC) curve and gene expression profiles: DAXX, EFNB1, NCOR2, RBBP4 and SOCS1. The function of 5 hub genes was analyzed and the interaction between drugs and hub genes was predicted. ...In summary …
Further, five hub genes were identified by receiver operating characteristic (ROC) curve and gene expression profiles: DAXX, EFNB1, N …
41 results